Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shing-Ling Tsai
Nuclear Translocation of Epidermal Growth Factor Receptor by Akt-Dependent Phosphorylation Enhances Breast Cancer-Resistant Protein Expression in Gefitinib-Resistant Cells
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Delivery of a Survivin Promoter-Driven Antisense Survivin-Expressing Plasmid DNA as a Cancer Therapeutic: A Proof-Of-Concept Study
OncoTargets and Therapy
Oncology
Pharmacology
Related publications
Autophagic Degradation of Epidermal Growth Factor Receptor in Gefitinib-Resistant Lung Cancer by Celastrol
International Journal of Oncology
Cancer Research
Oncology
Continuous Inhibition of Epidermal Growth Factor Receptor Phosphorylation by Erlotinib Enhances Antitumor Activity of Chemotherapy in Erlotinib-Resistant Tumor Xenografts
Oncology Reports
Medicine
Cancer Research
Oncology
Heregulin Β1 Drives Gefitinib-Resistant Growth and Invasion in Tamoxifen-Resistant McF-7 Breast Cancer Cells
Breast Cancer Research
Cancer Research
Oncology
Enhancement of Epidermal Growth Factor Receptor-Degradation Pathway in Acquired Gefitinib-Resistant Human Non-Small Cell Lung Cancer Cell Lines
The Showa University Journal of Medical Sciences
Silencing Kinase-Interacting Stathmin Gene Enhances Erlotinib Sensitivity by Inhibiting Ser10 P27 Phosphorylation in Epidermal Growth Factor Receptor-Expressing Breast Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Role of Epidermal Growth Factor Receptor in Breast Cancer
Breast Cancer Research and Treatment
Cancer Research
Oncology
Herceptin Enhances the Antitumor Effect of Natural Killer Cells on Breast Cancer Cells Expressing Human Epidermal Growth Factor Receptor-2
Frontiers in Immunology
Allergy
Immunology
Epidermal Growth Factor–Induced Signaling in Breast Cancer Cells Results in Selective Target Gene Activation by Orphan Nuclear Receptor Estrogen-Related Receptor Α
Cancer Research
Cancer Research
Oncology
The Synergistic Antitumor Effect of Combined Anti-Human Epidermal Growth Factor Receptor 2 Antibody and Gamma Interferon Therapy on Antibody-Resistant Breast Cancer Cells
The Showa University Journal of Medical Sciences
